Clinical RoundupFree Evidence from two studies demonstrates efficacy of Immunoscore May 29, 2020Vol.46 No.22
Clinical RoundupFree MK-6482 induced positive response in Hippel-Lindau disease–associated kidney cancer May 29, 2020Vol.46 No.22
FreeIn Brief Catherine Alfano, Stacy Sanchez, Joseph Herman, Martin Karpeh recruited by Northwell Cancer Institute May 29, 2020Vol.46 No.22
FreeIn Brief Pamela Hull joins Markey as associate director of population science and community impact May 29, 2020Vol.46 No.22
COVID-19 UpdatesFree Study: Hydroxychloroquine doesn’t improve survival in hospitalized COVID-19 patients, but tocilizumab does May 29, 2020Vol.46 No.22
COVID-19 UpdatesFree Genentech begins phase III trial of tocilizumab + remdesivir in hospitalized patients with severe COVID-19 pneumonia May 29, 2020Vol.46 No.22
COVID-19 UpdatesFree UMich develops app that calculates risk of delaying cancer care during COVID-19 May 29, 2020Vol.46 No.22
COVID-19 UpdatesFree ACS CAN survey: cancer patients increasingly face COVID-19 health impact May 29, 2020Vol.46 No.22
Conversation with The Cancer LetterCOVID-19 & CancerFree John Cleveland: How Moffitt will heal from conflict of interest trauma—and from COVID-19 May 29, 2020Vol.46 No.22By Matthew Bin Han Ong
COVID-19 & CancerFree Radiation oncology appointments plummeted in the COVID-19 pandemic—but seem to be rising again May 29, 2020Vol.46 No.22By Alexandria Carolan
